FTSE MIB
33.919,81 +38,31 (+0,11%) Dow Jones
37.930,94 +155,56 (+0,41%) Nasdaq
15.427,74 -173,76 (-1,11%) Nikkei 225
37.068,35 -1.011,35 (-2,66%) Petrolio
83,01 +0,28 (+0,34%) Bitcoin EUR
60.588,12 +873,28 (+1,46%)
iRhythm Technologies, Inc. (0A7L.L)
| Chiusura precedente | 111,10 |
| Aperto | 0,00 |
| Denaro | 0,00 x N/D |
| Lettera | 0,00 x N/D |
| Min-Max giorno | 0,00 - 0,00 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | 25 |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 1,31 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -4,22 |
| Prossima data utili | 02 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireiRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
Zio monitor Zio monitor by iRhythm iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.Zio® monitor builds on the high performance of Zio® XT that, together with its enhanced Zio® long term continuous cardiac monitoring service, provides an elevated end-to-end experienceZio monitor demonstrates high 99% patient compliance with prescribed wear times1 SAN FRANCISCO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the
GlobeNewswireiRhythm Technologies to Participate in Two Investor Conferences in September
SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the Company will be participating in the upcoming Baird 2023 Global Healthcare Conference and the Morgan Stanley 21st Annual Global Healthcare Conference. iRhythm’s management is scheduled to present at Baird’s 2023 Global Healthcare Conference on Tuesday, September 12
- GlobeNewswire
Zio Granted High Medical Needs Designation by the Japanese Ministry of Health, Labour, and Welfare
Designation reflects recommendation by the Japanese Heart Rhythm Society (JHRS) Shonin pre-market application submitted by iRhythm in July 2023 SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that its application for manufacturing and marketing approval for Zio Monitor System in Japan has been designated for high medical
